The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지

The Anti-tumor Effect of Bojungikkeehapdaechilkitang with Doxorubicin in Colon-26

보중익기합대칠기탕과 Doxorubicin의 병용이 Colon-26의 항암효과에 미치는 영향

  • 이윤희 (대구한의대학교 한의과대학 비계내과학교실) ;
  • 변준석 (대구한의대학교 한의과대학 비계내과학교실)
  • Published : 2004.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : To evaluate the anti-tumor and synergic effect of Bojungikkeehapdaechilki-tang (BJDC) with doxorubicin. Methods : The inhibitory concentration (IC), $IC_{50}{\;}and{\;}IC_{90}$ of single use of doxorubicin and BIDC with their concomitant treatment against Colon-26 (murine rectum carcinoma) cell line were observed using MTT (microculture tetrazolium test) assay. In addition, their anti-tumor effects were also observed in xenograft nude mice models against Colon-26 cell line. Results : BJDC had only minimal direct anti-tumor effect against Colon-26 cell line but it reduced general depressed signs induced by implantation of the tumor cell lines and increased the total WBC and lymphocyte numbers. Conclusions : It is considered or expected that BJDC extract is reducing the critical toxicity of doxorubicin and has favorable synergic anti-tumor effect when administered conconitently with doxorubicin.

Keywords

References

  1. 광제비급 1 李景華
  2. 종양학 3 서울대학교 의과대학
  3. 건강검진을 통한 암의 발견과 암표지자의 암선별검사로서의 유용성 박경희
  4. 건강생활년을 이용한 우리 나라 주요 암 질환의 질병부담 측정 최용준
  5. Anticancer Drugs v.11 no.10 The ex vivo effect of high concentrations of doxorubicin on recurrent ovarian carcinoma Neale MH;Lamont A;Hindley A;Kurbacher CM;Cree IA
  6. Expert Opin Investig Drugs v.9 no.7 New agents in the treatment of soft-tissue sarcomas Patel SR
  7. Cancer Res. v.61 no.8 Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart Sun X;Zhou Z;Kang YJ
  8. Nutr Cancer v.45 no.2 Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone Kirana C;McIntosh GH;Record IR;Jones GP
  9. 大韓韓方腫瘍學會誌 v.1 no.1 韓國韓醫學의 腫瘍硏究에 對한 現況 공현식;유봉하;박동원;유기원
  10. 大韓韓方內科學會誌 v.16 no.2 癌 治療에 있어서 扶正祛邪法의 運用에 關한 考察 孫彰奎;趙鍾寬
  11. 大韓韓方內科學會誌 v.16 no.2 現代 中國의 癌治療 硏究 現況 鄭鍾美;趙鍾寬
  12. 東醫寶鑑 4 許浚
  13. 대한한방내과학회지 v.22 no.1 한약을 이용한 항암 실험 연구의 경향과 연구 방향 임성우
  14. 方劑學(改正增補版) 金相贊;金先熙;盧昇鉉;朴宣東;卞晟僖;徐富一等
  15. 동의생리병리학회지 v.16 no.5 補中益氣湯이 생쥐의 특이적 면역반응에 미치는 영향 은재순;최훈;송정모
  16. 세명대학교 한의학연구소 논문집 v.3 補中益氣湯 合 香砂六君子湯이 복수암 유발 생쥐 비장의 세포성 면역활성에 미치는 영향에 관한 면역조직화학적 연구 김호현;김동환
  17. 동의생리병리학회지 v.15 no.1 大七氣湯이 抗癌, 免疫調節作用 및 apoptosis에 미치는 影響 하지용;정병억;이선구;유병길
  18. 大韓韓方內科學會誌 v.29 no.2 大七氣湯의 抗癌效果에 關한 硏究 禹弘楨;李長勳;金榮哲
  19. 大韓方劑學會誌 v.5 no.1 腫瘍의 治法에 關한 實驗的 硏究 김선희;김상찬;최종백
  20. 國譯 萬病回春 공정현
  21. 濟衆新編 康命吉
  22. Blood v.91 no.2 The tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Goralatide) protects from doxorubicin-induced toxicity: improvement in mice survival and protection of bone marrow stem cells and progenitors Masse A;Ramirez LH;Bindoula G;Grillon C;Wdzieczak-Bakala J;Raddassi K; Deschamps de Paillette E;Mencia-Huerta JM;Koscielny S;Potier P;Sainteny F;Carde P
  23. Laboratory profiles of small animal diseases. A guide to laboratory diagnosis (2nd ed.) Sodikoff CH
  24. 豫防醫學과 保健學 2 金光湖;南喆鉉;李起男;李仙童;蘇敬順;康坼林등
  25. 병리학 3 대한병리학회
  26. Ann Intern Med. v.91 no.5 Risk factors for doxorubicin-induced congestive heart failure Von Hoff DD;Layard MW;Basa P;Davis HL Jr;Von Hoff AL;Rozencweig M; Muggia FM
  27. Cancer Res. v.63 no.14 Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis Zhang DY;Wu J;Ye F;Xue L;Jiang S;Yi J;Zhang W;Wei H;Sung M;Wang W;Li X
  28. J Agric Food Chem. v.51 no.12 Antiproliferative and chemopreventive effects of adlay seed on lung cancer in vitro and in vivo Chang HC;Huang YC;Hung WC
  29. Phytother Res. v.17 no.4 DNA degradation by water extract of green tea in the presence of copper ions: implications for anticancer properties Malik A;Azam S;Hadi N;Hadi SM
  30. 儒門事親 1 張子和
  31. 醫學入門 1 이천
  32. Jpn J Cancer Res. v.89 no.12 Anti-cachectic effect of FK317, a novel anti-cancer agent, in colon26 and LX-1 models in mice Naoe Y;Kawamura I;Inami M;Matsumoto S;Nishigaki F;Tsujimoto S;Manda T; Shimomura K
  33. Anticancer Res. v.18 no.1A Effect of FR143430, a novel cytokine suppressive agent, on adenocarcinoma colon26- induced cachexia in mice Yamamoto N;Kawamura I;Nishigaki F;Tsujimoto S;Naoe Y;Inami M;Elizabeth L; Manda T;Shimomura K
  34. Acta Oncol. v.34 no.2 Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo Watanabe T;Tsuge H;Oh-Hara T;Naito M;Tsuruo T
  35. Oncol Res. v.9 no.2 Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines Nakanishi O;Baba M;Saito A;Yamashita T;Sato W;Abe H;Fukazawa N;Suzuki T; Sato S;Naito M;Tsuruo T
  36. Biochem Pharmacol. v.64 no.3 A novel stereo-selective sulfonylurea, 1-[1-(4-aminobenzoyl)-2,3-dihydro -1H-indol-6-sulfonyl]-4-phenyl-imidazolidin-2-one, has antitumor efficacy in in vitro and in vivo tumor models Lee CW;Hong DH;Han SB;Jung SH;Kim HC;Fine RL;Lee SH;Kim HM
  37. Jpn J Cancer Res. v.83 no.4 Effects of antitumor agents on subcutaneous implants and hepatic metastases of colon carcinoma 26 in mice Iigo M;Nishikata K;Nakajima Y;Araki E